Rapid RV/LV vs Viz RV/LV
AI Verdict
Choose Rapid RV/LV if…
Choose Rapid RV/LV if your institution prioritizes on-premises or hybrid deployment for greater control over data infrastructure and security. This tool is ideal for integrating seamlessly within an existing RapidAI ecosystem, leveraging its capabilities to reduce inter-rater variability in PE severity assessment.
View Rapid RV/LV →Choose Viz RV/LV if…
Choose Viz RV/LV if your care teams require a cloud-based solution that emphasizes rapid, mobile-accessible insights and robust care coordination. This tool is best suited for organizations looking to enhance communication and streamline workflows across multiple specialties through AI-powered alerts and a comprehensive HIPAA-compliant communication platform, as part of the broader Viz PE Solution.
View Viz RV/LV →When choosing between Rapid RV/LV by RapidAI and Viz RV/LV by Viz.ai, physicians should consider their existing infrastructure and desired workflow. Both are FDA-cleared AI tools designed to rapidly assess pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans, aiming to reduce inter-rater variability and provide quick results. They both offer annotated images showing ventricular measurements and are integrated into broader pulmonary embolism solutions.
The key practical difference lies in their deployment. Rapid RV/LV offers on-premises or hybrid deployment, connecting to the hospital LAN/firewall. This might be preferable for institutions with strict data residency requirements or those that favor managing their own infrastructure. In contrast, Viz RV/LV is cloud-based, which could appeal to organizations seeking a more scalable, maintenance-free solution with potentially faster implementation. Viz RV/LV also emphasizes its role in intelligent care coordination and offers a high-fidelity mobile DICOM image viewer and HIPAA-compliant communication platform as part of its broader Viz PE Solution.
Therefore, a physician prioritizing on-premises control and integration with an existing RapidAI platform might lean towards Rapid RV/LV. Conversely, a physician seeking a cloud-native solution with robust care coordination features and mobile image viewing capabilities, particularly if already utilizing the Viz.ai ecosystem, would likely find Viz RV/LV to be a more suitable choice.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Rapid RV/LV | Viz RV/LV |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Not publicly available |
| Deployment | On-premises (dedicated server or virtual machine) or hybrid (on-premises/cloud with secure link to cloud), connecting to hospital LAN/firewall. | Cloud-based |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz RV/LVViz RV/LV (Tool B) offers a high-fidelity mobile DICOM image viewer and a HIPAA-compliant communication platform for care coordination, suggesting a more integrated and accessible user experience within a broader care coordination platform. While Rapid RV/LV (Tool A) also provides integration and notification capabilities, Viz.ai's explicit mobile and communication features point to a potentially more streamlined workflow for care teams.
Clinical Value
TieBoth Rapid RV/LV (Tool A) and Viz RV/LV (Tool B) are FDA-cleared AI tools designed for the rapid assessment of pulmonary embolism severity by automating RV/LV ratio measurements from CTPA scans. Both aim to improve rapid risk stratification and clinical decision-making. Without specific comparative clinical outcome data or unique differentiating clinical features beyond their core function, it is difficult to distinguish a clear winner in terms of clinical value.
Pricing & Value
TieNeither Rapid RV/LV (Tool A) nor Viz RV/LV (Tool B) provides publicly available pricing information, requiring potential customers to contact the vendor directly for details. This lack of transparency makes a direct comparison of their pricing and overall value proposition impossible. Therefore, it is not possible to determine a winner in this dimension.
Enterprise Readiness
TieBoth tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), demonstrating their readiness for enterprise deployment. Rapid RV/LV (Tool A) provides flexible on-premises or hybrid deployment options, which may suit organizations with specific infrastructure preferences, while Viz RV/LV (Tool B)'s cloud-based deployment offers scalability and potentially simpler IT management. Both deployment models are robust for enterprise environments.
Innovation
Viz RV/LVWhile both tools leverage AI for automated RV/LV ratio measurement, Viz RV/LV (Tool B) demonstrates a broader scope of innovation by emphasizing its seamless integration into the Viz PE Solution, including AI-powered alerts, notifications to care teams, and a HIPAA-compliant communication platform. This focus on integrated care coordination and mobile accessibility extends beyond just image analysis, offering a more comprehensive innovative approach.
Support & Docs
Viz RV/LVViz.ai (Tool B) offers 24x7 urgent support with a 15-minute response time for critical issues, along with a dedicated customer success team, a Knowledge Base, and 'Viz Academy' for comprehensive customer enablement and workflow optimization. RapidAI (Tool A) also provides 24/7/365 customer support and various resources, but Viz.ai's emphasis on proactive customer success and educational platforms provides a slight edge in overall support ecosystem.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rapid RV/LV | Viz RV/LV |
|---|---|---|
| Product Name | Rapid RV/LV | Viz RV/LV |
| Company | RapidAI (formerly iSchemaView) | Viz.ai |
| Description | FDA-cleared AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. | FDA-cleared AI algorithm that automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification and enhanced care coordination within the Viz PE Solution. |
| Key Feature: Automated RV/LV Ratio | Automated measurement of right and left ventricle diameters, Calculation of RV/LV ratio | Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement |
| Key Feature: Annotated Images | Annotated images showing ventricular measurements | Provides annotated images showing ventricular measurements |
| Key Feature: Integration with PE Solution | Integration with Rapid PE solution | Seamless component of the Viz PE Solution for suspected pulmonary embolism detection |
| Specialties | Cardiology, Pulmonology, Radiology | Emergency Medicine, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Rapid RV/LV and Viz RV/LV.